Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: March 17, 2026, 4:30 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 524604 | NSE: ADLINE

Adline Chem Lab Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹82.13Undervalued by 557.04%vs CMP ₹12.50

P/E (244.0) × ROE (15.0%) × BV (₹2.75) × DY (2.00%)

Defaults: ROE=15%

₹20.84Undervalued by 66.72%vs CMP ₹12.50
MoS: +40% (Strong)Confidence: 38/100 (Low)Models: 1 Under, 2 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹43.2847%Under (+246.2%)
Graham NumberEarnings₹1.7635%Over (-85.9%)
Earnings YieldEarnings₹0.5019%Over (-96%)
Consensus (3 models)₹20.84100%Undervalued
Key Drivers: EPS CAGR -47.3% drags value — could be higher if earnings stabilize. | P/E of 244 makes PE-ROE unreliable — asset/earnings models are better benchmarks.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -47.3% · Defaults: ROE=15%

*Investments are subject to market risks

Investment Snapshot

40
Adline Chem Lab Ltd scores 40/100 (Weak)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health18/100 · Weak
ROCE 0.0% WeakROE 0.0% WeakD/E 1.30 High debtInterest Coverage 0.0x RiskyProfitable 1/5 years Inconsistent
Smart Money35/100 · Weak
Promoter decreased by 3.76% Caution
Earnings Quality65/100 · Strong
OPM expanding (-20% → 0%) Improving
Quarterly Momentum50/100 · Moderate
Industry Rank30/100 · Weak
P/E 244.0 vs industry 53.8 Premium to peers3Y sales CAGR: -100% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: March 17, 2026, 4:30 am

Market Cap 7.31 Cr.
Current Price 12.5
Intrinsic Value₹20.84
High / Low 19.1/7.60
Stock P/E244
Book Value 2.75
Dividend Yield0.00 %
ROCE%
ROE%
Face Value 10.0
PEG Ratio-5.16

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Adline Chem Lab Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Adline Chem Lab Ltd 7.31 Cr. 12.5 19.1/7.60244 2.750.00 %%% 10.0
Sequent Scientific Ltd 8,768 Cr. 201 260/111203 32.20.00 %8.47 %3.21 % 2.00
Wockhardt Ltd 20,598 Cr. 1,268 1,870/1,087190 2810.00 %3.75 %1.22 % 5.00
Achyut Healthcare Ltd 132 Cr. 5.62 6.80/3.00308 1.340.00 %2.26 %1.77 % 1.00
Concord Drugs Ltd 70.6 Cr. 70.6 92.5/29.0133 34.40.00 %4.73 %0.88 % 10.0
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Adline Chem Lab Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 0.000.000.000.000.000.000.000.000.000.000.000.000.00
Expenses 0.410.080.080.030.000.070.100.070.100.060.030.050.03
Operating Profit -0.41-0.08-0.08-0.030.00-0.07-0.10-0.07-0.10-0.06-0.03-0.05-0.03
OPM %
Other Income 0.390.070.000.000.000.030.000.000.000.250.000.000.00
Interest 0.000.000.000.030.030.000.030.030.030.030.030.030.04
Depreciation 0.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax -0.02-0.01-0.08-0.06-0.03-0.04-0.13-0.10-0.130.16-0.06-0.08-0.07
Tax % 0.00%0.00%0.00%-16.67%-33.33%0.00%-7.69%-10.00%-7.69%-31.25%-16.67%-12.50%-14.29%
Net Profit -0.02-0.01-0.08-0.05-0.02-0.04-0.13-0.09-0.120.21-0.05-0.07-0.06
EPS in Rs -0.03-0.02-0.14-0.09-0.03-0.07-0.22-0.15-0.210.36-0.09-0.12-0.10

Last Updated: March 3, 2026, 1:01 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 3:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 13.4515.3616.9417.188.105.596.596.330.740.000.000.000.00
Expenses 12.4314.4216.5015.977.235.019.916.561.040.800.180.300.17
Operating Profit 1.020.940.441.210.870.58-3.32-0.23-0.30-0.80-0.18-0.30-0.17
OPM % 7.58%6.12%2.60%7.04%10.74%10.38%-50.38%-3.63%-40.54%
Other Income 0.020.080.100.080.210.250.260.001.33-3.350.000.250.25
Interest 0.570.480.440.320.340.070.020.030.010.000.120.160.13
Depreciation 0.460.510.090.960.730.730.421.020.350.090.000.000.00
Profit before tax 0.010.030.010.010.010.03-3.50-1.280.67-4.24-0.30-0.21-0.05
Tax % 0.00%33.33%100.00%0.00%100.00%0.00%7.43%0.00%-7.46%0.00%-10.00%-33.33%
Net Profit 0.010.020.010.010.000.03-3.76-1.280.72-4.23-0.27-0.130.03
EPS in Rs 0.020.030.020.020.000.05-6.43-2.191.23-7.23-0.46-0.220.05
Dividend Payout % 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)100.00%-50.00%0.00%-100.00%-12633.33%65.96%156.25%-687.50%93.62%51.85%
Change in YoY Net Profit Growth (%)0.00%-150.00%50.00%-100.00%-12533.33%12699.29%90.29%-843.75%781.12%-41.77%

Adline Chem Lab Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:%
TTM:%
Compounded Profit Growth
10 Years:%
5 Years:14%
3 Years:19%
TTM:79%
Stock Price CAGR
10 Years:%
5 Years:29%
3 Years:24%
1 Year:-13%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:%

Last Updated: September 5, 2025, 2:06 pm

Balance Sheet

Last Updated: December 4, 2025, 2:18 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 5.855.855.855.855.855.855.855.855.855.855.855.855.85
Reserves 1.211.211.211.191.181.18-2.64-3.92-3.20-7.42-7.22-7.34-7.46
Borrowings 6.699.259.019.9411.325.352.852.501.321.331.361.491.65
Other Liabilities 2.772.322.343.975.019.461.521.200.910.310.060.080.08
Total Liabilities 16.5218.6318.4120.9523.3621.847.585.634.880.070.050.080.12
Fixed Assets 8.1710.0810.2712.6812.4511.994.783.644.430.000.000.000.00
CWIP 0.200.200.200.000.000.000.000.000.000.000.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 8.158.357.948.2710.919.852.801.990.450.070.050.080.12
Total Assets 16.5218.6318.4120.9523.3621.847.585.634.880.070.050.080.12

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 1.310.390.832.460.89-0.95-11.34-0.290.210.01-0.17-0.23
Cash from Investing Activity + -1.04-2.44-0.21-3.18-0.37-0.2811.240.120.000.000.000.00
Cash from Financing Activity + -0.092.18-0.780.631.04-0.29-0.02-0.03-0.010.000.150.25
Net Cash Flow 0.180.12-0.15-0.091.56-1.51-0.12-0.210.200.01-0.020.02
Free Cash Flow 0.27-2.060.62-0.730.36-1.23-0.10-0.170.210.01-0.17-0.23
CFO/OP 128%41%189%203%102%-164%342%126%-70%-1%94%110%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-5.67-8.31-8.57-8.73-10.45-4.77-6.17-2.73-1.62-2.13-1.54-1.79

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 53.4657.7453.8756.30102.74135.8179.2091.1134.53
Inventory Days 109.2577.6746.1555.54181.31832.8281.5346.98197.710.00
Days Payable 45.4243.1241.3949.2463.34436.9741.8928.91342.19
Cash Conversion Cycle 117.3092.3058.6262.60220.71531.66118.84109.18-109.95
Working Capital Days 47.7624.71-6.46-29.53-139.69-317.99-72.00-66.89-764.53
ROCE %4.29%3.39%2.84%2.00%1.98%0.59%-40.35%-23.83%-10.95%5.90%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 28.24%28.24%28.24%28.24%29.61%29.61%29.61%29.61%29.61%29.61%29.61%25.85%
Public 71.77%71.77%71.76%71.75%70.40%70.39%70.39%70.39%70.39%70.39%70.38%74.15%
No. of Shareholders 18,67018,66118,63818,62818,59518,58418,53618,50918,51418,48118,48818,468

Shareholding Pattern Chart

No. of Shareholders

Adline Chem Lab Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -0.21-0.25-7.241.23-2.19
Diluted EPS (Rs.) -0.21-0.25-7.241.23-2.19
Cash EPS (Rs.) -0.22-0.25-7.091.83-0.44
Book Value[Excl.RevalReserv]/Share (Rs.) -2.55-2.93-2.684.533.30
Book Value[Incl.RevalReserv]/Share (Rs.) -2.55-2.93-2.684.533.30
Revenue From Operations / Share (Rs.) 0.000.000.001.2610.82
PBDIT / Share (Rs.) -0.07-0.240.33-0.19-0.38
PBIT / Share (Rs.) -0.07-0.240.18-0.78-2.14
PBT / Share (Rs.) -0.35-0.24-7.241.15-2.19
Net Profit / Share (Rs.) -0.22-0.25-7.241.23-2.19
PBDIT Margin (%) 0.000.000.00-15.18-3.60
PBIT Margin (%) 0.000.000.00-62.71-19.77
PBT Margin (%) 0.000.000.0091.22-20.28
Net Profit Margin (%) 0.000.000.0097.44-20.28
Return on Networth / Equity (%) 0.000.000.0027.10-66.47
Return on Capital Employeed (%) -74.8310.03-8.69-15.66-53.59
Return On Assets (%) -175.09-347.38-6858.2614.72-22.77
Long Term Debt / Equity (X) -0.990.000.000.000.00
Total Debt / Equity (X) -0.99-0.86-0.850.491.30
Asset Turnover Ratio (%) 0.000.000.000.140.95
Current Ratio (X) 4.460.020.040.220.60
Quick Ratio (X) 4.460.020.040.090.48
Interest Coverage Ratio (X) -0.270.000.00-15.19-6.97
Interest Coverage Ratio (Post Tax) (X) 0.170.000.00-56.48-38.25
Enterprise Value (Cr.) 9.1818.234.435.115.64
EV / Net Operating Revenue (X) 0.000.000.006.930.89
EV / EBITDA (X) -204.49-124.9522.32-45.65-24.76
MarketCap / Net Operating Revenue (X) 0.000.000.005.210.47
Price / BV (X) -5.20-9.80-2.021.451.55
Price / Net Operating Revenue (X) 0.000.000.005.210.47
EarningsYield -0.01-0.01-1.340.18-0.43

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Adline Chem Lab Ltd. is a Public Limited Listed company incorporated on 06/07/1988 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1988PLC010956 and registration number is 010956. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 5.85 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Pharmaceuticals403, Sarthik II, Opp. Rajpath Club, Ahmedabad Gujarat 380054Contact not found
Management
NamePosition Held
Mr. Sarang Bharatbhai PathakManaging Director
Mr. Hemant Amrish ParikhDirector
Mr. Dhawal Akhilesh DeopuraDirector
Ms. Shivani PathakDirector
Mr. Vrushank Balkrushna PatelAdditional Director
Mr. Nilay Jitendrabhai VaghasiyaAdditional Director

FAQ

What is the intrinsic value of Adline Chem Lab Ltd and is it undervalued?

As of 13 April 2026, Adline Chem Lab Ltd's intrinsic value is ₹20.84, which is 66.72% higher than the current market price of ₹12.50, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (%), book value (₹2.75), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Adline Chem Lab Ltd?

Adline Chem Lab Ltd is trading at ₹12.50 as of 13 April 2026, with a FY2026-2027 high of ₹19.1 and low of ₹7.60. The stock is currently in the middle of its 52-week range. Market cap stands at ₹7.31 Cr..

How does Adline Chem Lab Ltd's P/E ratio compare to its industry?

Adline Chem Lab Ltd has a P/E ratio of 244, which is above the industry average of 53.84. This significantly elevated P/E suggests the market expects strong future growth, or the stock may be overpriced relative to current earnings.

Is Adline Chem Lab Ltd financially healthy?

Key indicators for Adline Chem Lab Ltd: ROCE of % is on the lower side compared to the industry average of 16.35%; ROE of % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.

Is Adline Chem Lab Ltd profitable and how is the profit trend?

Adline Chem Lab Ltd reported a net profit of ₹0 Cr in Mar 2025. Compared to ₹1 Cr in Mar 2022, the net profit shows a declining trend.

Does Adline Chem Lab Ltd pay dividends?

Adline Chem Lab Ltd has a dividend yield of 0.00 % at the current price of ₹12.50. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Adline Chem Lab Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports